Skip to Main Content

Paper Details

Safety and Efficacy of Ustekinumab in the Inflammatory Bowel Disease of Chronic Granulomatous Disease.
Clin Gastroenterol Hepatol
7
2022
Author NameAffiliation
Martha QuezadoNational Cancer Institute, National Institutes of Health
Martha QuezadoNational Cancer Institute, National Institutes of Health
Theo HellerNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
Theo HellerNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
  • 1 - 4

Datasets

Release 1.2